BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8698855)

  • 21. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine.
    Lima AA; Innes DJ; Chadee K; Lyerly DM; Wilkins TD; Guerrant RL
    Lab Invest; 1989 Oct; 61(4):419-25. PubMed ID: 2507823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model.
    Alcantara CS; Jin XH; Brito GA; Carneiro-Filho BA; Barrett LJ; Carey RM; Guerrant RL
    J Infect Dis; 2005 Jun; 191(12):2090-6. PubMed ID: 15897995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of phospholipase A2 and tyrosine kinase in Clostridium difficile toxin A-induced disruption of epithelial integrity, histologic inflammatory damage and intestinal secretion.
    Lima AA; Nascimento NR; Fang GD; Yotseff P; Toyama MH; Guerrant RL; Fonteles MC
    J Appl Toxicol; 2008 Oct; 28(7):849-57. PubMed ID: 18381687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli strain RDEC-1 AF/R1 endogenous fimbrial glycoconjugate receptor molecules in rabbit small intestine.
    Ryu H; Kim YS; Grange PA; Cassels FJ
    Infect Immun; 2001 Feb; 69(2):640-9. PubMed ID: 11159950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
    Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
    PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile toxin A binding to human intestinal epithelial cells.
    Smith JA; Cooke DL; Hyde S; Borriello SP; Long RG
    J Med Microbiol; 1997 Nov; 46(11):953-8. PubMed ID: 9368537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of Clostridium difficile crude toxins and purified toxin A on stripped rabbit ileal mucosa in Ussing chambers.
    Mitchell TJ; Ketley JM; Burdon DW; Candy DC; Stephen J
    J Med Microbiol; 1987 May; 23(3):199-204. PubMed ID: 2856844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of Clostridium difficile toxins A and B on rabbit ileum.
    Triadafilopoulos G; Pothoulakis C; O'Brien MJ; LaMont JT
    Gastroenterology; 1987 Aug; 93(2):273-9. PubMed ID: 3596162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits.
    Ketley JM; Mitchell TJ; Candy DC; Burdon DW; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):41-52. PubMed ID: 3612743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
    Castagliuolo I; LaMont JT; Nikulasson ST; Pothoulakis C
    Infect Immun; 1996 Dec; 64(12):5225-32. PubMed ID: 8945570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of toxicity and haemorrhagic toxin produced by Clostridium sporogenes in various animals and cultured cells.
    Hara-Kudo Y; Ogura A; Noguchi Y; Kumagai S
    J Med Microbiol; 1997 Apr; 46(4):270-5. PubMed ID: 9128190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.
    Pothoulakis C; Kelly CP; Joshi MA; Gao N; O'Keane CJ; Castagliuolo I; Lamont JT
    Gastroenterology; 1993 Apr; 104(4):1108-15. PubMed ID: 8462799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
    Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of purified Clostridium difficile toxins on intestinal smooth muscle. I. Toxin A.
    Gilbert RJ; Triadafilopoulos G; Pothoulakis C; Giampaolo C; LaMont JT
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G759-66. PubMed ID: 2495733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin.
    Mitchell TJ; Ketley JM; Burdon DW; Candy DC; Stephen J
    J Med Microbiol; 1987 May; 23(3):211-9. PubMed ID: 3585958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and sequencing of a full-length rat sucrase-isomaltase-encoding cDNA.
    Chandrasena G; Osterholm DE; Sunitha I; Henning SJ
    Gene; 1994 Dec; 150(2):355-60. PubMed ID: 7821806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholera toxin entry into pig enterocytes occurs via a lipid raft- and clathrin-dependent mechanism.
    Hansen GH; Dalskov SM; Rasmussen CR; Immerdal L; Niels-Christiansen LL; Danielsen EM
    Biochemistry; 2005 Jan; 44(3):873-82. PubMed ID: 15654743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of purified Clostridium difficile toxins on intestinal smooth muscle. II. Toxin B.
    Gilbert RJ; Pothoulakis C; LaMont JT
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G767-72. PubMed ID: 2495734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution and density of Clostridium difficile toxin receptors on the intestinal mucosa of neonatal pigs.
    Keel MK; Songer JG
    Vet Pathol; 2007 Nov; 44(6):814-22. PubMed ID: 18039894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
    Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
    J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.